Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity
Identifieur interne : 001666 ( Main/Exploration ); précédent : 001665; suivant : 001667Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity
Auteurs : Pawel Mielnik [Pologne] ; Hanna Chwalinska-Sadowska [Pologne] ; Ewa Wiesik-Szewczyk [Pologne] ; Wlodzimierz Maslinski [Pologne] ; Marzena Olesinska [Pologne]Source :
- Rheumatology International [ 0172-8172 ] ; 2012-03-01.
English descriptors
Abstract
Abstract: Cytokines are implied in polymyositis/dermatomyositis (PM/DM) pathogenesis. Our aim was to evaluate the serum levels of interleukin-15 (IL-15), soluble receptors for IL-2 (sIL-2R) and TNF-alpha type 1 receptor (sTNF-R1) in PM/DM patients and their relation to disease activity and clinical symptoms. Thirty-eight patients who met definite or probable criteria of Bohan and Peter for DM/PM were included into the study. Results in patients with active (41 observations) and inactive disease (24 observations) were compared with control (15 subjects). The median level of IL-15 was 47.6 ± 170 pg/ml in active patients, 25.15 ± 240 pg/ml in inactive and 28.5 ± 28.89 pg/ml in controls. We demonstrated significant differences between active patients and controls in levels of IL-15 (0.016, 95%CI 1.39–57.1). The median level of sIL-2R was 314 ± 388, 235.3 ± 269 and 144.3 ± 152.9 pg/ml, and the median level of sTNF-R1 was 350 ± 388; 294.7 ± 204.7; 209.5 ± 105.9 pg/ml in active, inactive and control subjects, respectively. There were significantly higher serum levels of these cytokines in active patients than in control subjects (for sIL-2R P = 0.05, CI95% 0.4–331; and sTNF-R1 P = 0.031, CI95% 15.1–321.5). The interleukin levels did not differ between inactive patients and controls. Elevation of IL-15, sIL2-R and sTNF-R1 in active patients provides preliminary evidence for the activation of inflammatory response during PM/DM flares. Further studies may be needed to explain the mechanisms driving these diseases.
Url:
DOI: 10.1007/s00296-010-1692-y
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002889
- to stream Istex, to step Curation: 002889
- to stream Istex, to step Checkpoint: 000611
- to stream Main, to step Merge: 001669
- to stream Main, to step Curation: 001666
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity</title><author><name sortKey="Mielnik, Pawel" sort="Mielnik, Pawel" uniqKey="Mielnik P" first="Pawel" last="Mielnik">Pawel Mielnik</name></author><author><name sortKey="Chwalinska Sadowska, Hanna" sort="Chwalinska Sadowska, Hanna" uniqKey="Chwalinska Sadowska H" first="Hanna" last="Chwalinska-Sadowska">Hanna Chwalinska-Sadowska</name></author><author><name sortKey="Wiesik Szewczyk, Ewa" sort="Wiesik Szewczyk, Ewa" uniqKey="Wiesik Szewczyk E" first="Ewa" last="Wiesik-Szewczyk">Ewa Wiesik-Szewczyk</name></author><author><name sortKey="Maslinski, Wlodzimierz" sort="Maslinski, Wlodzimierz" uniqKey="Maslinski W" first="Wlodzimierz" last="Maslinski">Wlodzimierz Maslinski</name></author><author><name sortKey="Olesinska, Marzena" sort="Olesinska, Marzena" uniqKey="Olesinska M" first="Marzena" last="Olesinska">Marzena Olesinska</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:7499C985AEE33F843EBB96ACE2E003B4875B2BE1</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1007/s00296-010-1692-y</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-MBJZJ476-0/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002889</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002889</idno><idno type="wicri:Area/Istex/Curation">002889</idno><idno type="wicri:Area/Istex/Checkpoint">000611</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000611</idno><idno type="wicri:doubleKey">0172-8172:2010:Mielnik P:serum:concentration:of</idno><idno type="wicri:Area/Main/Merge">001669</idno><idno type="wicri:Area/Main/Curation">001666</idno><idno type="wicri:Area/Main/Exploration">001666</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity</title><author><name sortKey="Mielnik, Pawel" sort="Mielnik, Pawel" uniqKey="Mielnik P" first="Pawel" last="Mielnik">Pawel Mielnik</name><affiliation wicri:level="1"><country xml:lang="fr">Pologne</country><wicri:regionArea>Department of Connective Tissue Diseases, Institute of Rheumatology, Spartanska 1, Warsaw</wicri:regionArea><wicri:noRegion>Warsaw</wicri:noRegion></affiliation><affiliation></affiliation></author><author><name sortKey="Chwalinska Sadowska, Hanna" sort="Chwalinska Sadowska, Hanna" uniqKey="Chwalinska Sadowska H" first="Hanna" last="Chwalinska-Sadowska">Hanna Chwalinska-Sadowska</name><affiliation wicri:level="1"><country xml:lang="fr">Pologne</country><wicri:regionArea>Department of Connective Tissue Diseases, Institute of Rheumatology, Spartanska 1, Warsaw</wicri:regionArea><wicri:noRegion>Warsaw</wicri:noRegion></affiliation></author><author><name sortKey="Wiesik Szewczyk, Ewa" sort="Wiesik Szewczyk, Ewa" uniqKey="Wiesik Szewczyk E" first="Ewa" last="Wiesik-Szewczyk">Ewa Wiesik-Szewczyk</name><affiliation wicri:level="1"><country xml:lang="fr">Pologne</country><wicri:regionArea>Department of Connective Tissue Diseases, Institute of Rheumatology, Spartanska 1, Warsaw</wicri:regionArea><wicri:noRegion>Warsaw</wicri:noRegion></affiliation></author><author><name sortKey="Maslinski, Wlodzimierz" sort="Maslinski, Wlodzimierz" uniqKey="Maslinski W" first="Wlodzimierz" last="Maslinski">Wlodzimierz Maslinski</name><affiliation wicri:level="1"><country xml:lang="fr">Pologne</country><wicri:regionArea>Department of Pathophysiology and Immunology, Institute of Rheumatology, Warsaw</wicri:regionArea><wicri:noRegion>Warsaw</wicri:noRegion></affiliation></author><author><name sortKey="Olesinska, Marzena" sort="Olesinska, Marzena" uniqKey="Olesinska M" first="Marzena" last="Olesinska">Marzena Olesinska</name><affiliation wicri:level="1"><country xml:lang="fr">Pologne</country><wicri:regionArea>Department of Connective Tissue Diseases, Institute of Rheumatology, Spartanska 1, Warsaw</wicri:regionArea><wicri:noRegion>Warsaw</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Rheumatology International</title><title level="j" type="sub">Clinical and Experimental Investigations</title><title level="j" type="abbrev">Rheumatol Int</title><idno type="ISSN">0172-8172</idno><idno type="eISSN">1437-160X</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="2012-03-01">2012-03-01</date><biblScope unit="volume">32</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="639">639</biblScope><biblScope unit="page" to="643">643</biblScope></imprint><idno type="ISSN">0172-8172</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0172-8172</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dermatomyositis</term><term>Disease activity</term><term>Interleukin-15</term><term>Polymyositis</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Cytokines are implied in polymyositis/dermatomyositis (PM/DM) pathogenesis. Our aim was to evaluate the serum levels of interleukin-15 (IL-15), soluble receptors for IL-2 (sIL-2R) and TNF-alpha type 1 receptor (sTNF-R1) in PM/DM patients and their relation to disease activity and clinical symptoms. Thirty-eight patients who met definite or probable criteria of Bohan and Peter for DM/PM were included into the study. Results in patients with active (41 observations) and inactive disease (24 observations) were compared with control (15 subjects). The median level of IL-15 was 47.6 ± 170 pg/ml in active patients, 25.15 ± 240 pg/ml in inactive and 28.5 ± 28.89 pg/ml in controls. We demonstrated significant differences between active patients and controls in levels of IL-15 (0.016, 95%CI 1.39–57.1). The median level of sIL-2R was 314 ± 388, 235.3 ± 269 and 144.3 ± 152.9 pg/ml, and the median level of sTNF-R1 was 350 ± 388; 294.7 ± 204.7; 209.5 ± 105.9 pg/ml in active, inactive and control subjects, respectively. There were significantly higher serum levels of these cytokines in active patients than in control subjects (for sIL-2R P = 0.05, CI95% 0.4–331; and sTNF-R1 P = 0.031, CI95% 15.1–321.5). The interleukin levels did not differ between inactive patients and controls. Elevation of IL-15, sIL2-R and sTNF-R1 in active patients provides preliminary evidence for the activation of inflammatory response during PM/DM flares. Further studies may be needed to explain the mechanisms driving these diseases.</div></front></TEI><affiliations><list><country><li>Pologne</li></country></list><tree><country name="Pologne"><noRegion><name sortKey="Mielnik, Pawel" sort="Mielnik, Pawel" uniqKey="Mielnik P" first="Pawel" last="Mielnik">Pawel Mielnik</name></noRegion><name sortKey="Chwalinska Sadowska, Hanna" sort="Chwalinska Sadowska, Hanna" uniqKey="Chwalinska Sadowska H" first="Hanna" last="Chwalinska-Sadowska">Hanna Chwalinska-Sadowska</name><name sortKey="Maslinski, Wlodzimierz" sort="Maslinski, Wlodzimierz" uniqKey="Maslinski W" first="Wlodzimierz" last="Maslinski">Wlodzimierz Maslinski</name><name sortKey="Olesinska, Marzena" sort="Olesinska, Marzena" uniqKey="Olesinska M" first="Marzena" last="Olesinska">Marzena Olesinska</name><name sortKey="Wiesik Szewczyk, Ewa" sort="Wiesik Szewczyk, Ewa" uniqKey="Wiesik Szewczyk E" first="Ewa" last="Wiesik-Szewczyk">Ewa Wiesik-Szewczyk</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001666 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001666 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:7499C985AEE33F843EBB96ACE2E003B4875B2BE1
|texte= Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity
}}
| This area was generated with Dilib version V0.6.33. |  |